Meglumine diatrizoate
Meglumine diatrizoate Brand names, Meglumine diatrizoate Analogs
- Acide amidotrizoique
- Acidum amidotrizoicum
- Acidum diacetylaminotrijodbenzoicum
- AmiDOTrizoic acid
- Amidotrizoate
- Angiovist 282
- Cardiografin
- Conray 35
- DIAT [German]
- Diat
- Diatriazoate
- Diatrizoate sodium
- Diatrizoate sodium salt
- Diatrizoesaeure
- Diatrizoesaure
- Diatrizoesaure [German]
- Diatrizoic acid
- Diatrizoic acid [USAN:BAN]
- Diatrizoic acid sodium salt
- Gastrografin
- Hypaque
- Hypaque 50
- Hypaque sodium
- Iothalamate
- Meglumine diatrizoate
- Methalamic acid
- Odiston
- Reno-dip
- Renografin 76
- Sodium amidotrizoate
- Sodium diatrizoate
- Triombrin
- Triombrin [Russian]
- Triombrine
- Urografic acid, sodium salt
- Urografin acid
- Urogranoic acid
- Urotrast
- Urovison
- Urovist Cysto
- Urovist Cysto Pediatric
- Urovist Meglumine Diu/ct
- Urovist Sodium 300
- Vascoray
Meglumine diatrizoate Brand Names Mixture
- No information avaliable
Meglumine diatrizoate Chemical_Formula
C9H15N5O3
Meglumine diatrizoate RX_link
No information avaliable
Meglumine diatrizoate fda sheet
Meglumine diatrizoate msds (material safety sheet)
Meglumine diatrizoate Synthesis Reference
No information avaliable
Meglumine diatrizoate Molecular Weight
241.247 g/mol
Meglumine diatrizoate Melting Point
250-255 oC (hydrochloride salt)
Meglumine diatrizoate H2O Solubility
>20 mg/mL (dichloride salt)
Meglumine diatrizoate State
Solid
Meglumine diatrizoate LogP
-1.783
Meglumine diatrizoate Dosage Forms
No information avaliable
Meglumine diatrizoate Indication
For the treatment of tetrahydrobiopterin (BH4) deficiency.
Meglumine diatrizoate Pharmacology
Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.
Meglumine diatrizoate Absorption
No information avaliable
Meglumine diatrizoate side effects and Toxicity
No information avaliable
Meglumine diatrizoate Patient Information
No information avaliable
Meglumine diatrizoate Organisms Affected
Humans and other mammals
